Tice-BCG
Tice-BCG is a vaccine used to lower the risk of getting tuberculosis in persons who may be exposed to the disease.
Primary Characteristics
It is of origin and belongs to .
It is classified in Antitumor, Live attenuated strains of M. Bovis pharmacological group. It is also classified under CDC Biologicals .
Solubility in Water: null · Solubility in Alcohol: null · Non-proprietary name: Tice-BCG.
Pharmacokinetics
Distribution: Tice-BCG has a volume of distribution is . plasma protein binding is .
Elimination: it is metabolised via , plasma half-life is , renal excretion is .
Advertisement
Indications
Tice-BCG is primarily indicated in conditions like Bladder carcinoma, Urethelial cell carcinoma.
Contraindications
Tice-BCG is contraindicated in conditions like AIDS, Immunosuppression.
Dosage
Tice-BCG's dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 81 mg | 81 mg | — | Intra Bladder | Diluted in 50ml NS, instilled into empty bladder for 1-2hr as tolerated.. |
| Paediatric Dosage (20kg) | ||||
| 0 – 0 | — | — | Not applicable in paeds | |
| Neonatal Dosage (3kg) | ||||
| 0 – 0 | — | — | Not recommended in this age group | |
Drug Interactions
Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Side Effects
Tice-BCG in overdosage may give rise to further complications which include Arthralgia , Anemia , Anemia, Malaise , Anemia , Renal toxicity , Leukopenia.
Tice-BCG is known to cause more or less tolerable side effects which are usually transient. These include Abdominal pain, Anorexia , Cramps , Cystitis, Diarrhea, Dysuria, Genital pain, Hematuria, Nausea and vomiting, Urinary frequency, UTI .
Warnings / Precautions
Available Brands
None recorded.
Storage Conditions
Drug Classification
- 1.8.1 — Immunomodulators